CIP
PRAH

Convergence Investment Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History

Convergence Investment Partners’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13,923
Closed -$1.38M – 375
2019
Q2 		$1.38M Buy
+13,923
New +$1.33M 0.33% 114
2017
Q3 		– Sell
-30,843
Closed -$2.31M – 416
2017
Q2 		$2.31M Buy
+30,843
New +$2.14M 0.34% 110
2016
Q2 		– Sell
-89,268
Closed -$3.82M – 400
2016
Q1 		$3.82M Buy
+89,268
New +$3.77M 0.45% 80

Other funds holding PRAH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Convergence Investment Partners's PRAH Position: Q3 2019 in Review

Convergence Investment Partners sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2019, closing a stake of 13,923 shares — an estimated $1.38M sold.

Convergence Investment Partners first reported a position in PRAH in Q1 2016 and held it in 3 quarters. The position peaked at $3.82M in Q1 2016. 329 funds tracked by Wall St. Rank hold PRAH as of Q3 2019.

  • Convergence Investment Partners reported no remaining PRA Health Sciences, Inc. position as of Q3 2019 after selling out during the quarter.
  • Convergence Investment Partners sold 13,923 PRA Health Sciences, Inc. shares in Q3 2019, an estimated $1.38M.
  • Convergence Investment Partners first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 3 quarters.
  • Convergence Investment Partners's PRA Health Sciences, Inc. position peaked at $3.82M in Q1 2016.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2019.

Based on Convergence Investment Partners's 13F filing for Q3 2019, filed 22 Oct 2019.